COMMUNIQUÉS West-GlobeNewswire

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01
22/01/2026
STAFFORD, Texas, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio
22/01/2026
NEW YORK and SAVONA, Italy, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic [...]
Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.
22/01/2026
LAUPHEIM, Germany and MILFORD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that [...]
ProPhase Labs Uplists from Pink Sheets to OTC Market
22/01/2026
UNIONDALE, NY, Jan. 22, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (“ProPhase” or the “Company”), a diversified life sciences and diagnostics company, today announced that its common stock has been approved and [...]
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026
22/01/2026
Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new Orion cortical stimulation system for visual perception, designed to treat most common forms [...]
SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer
22/01/2026
The Daytrip IPA series grows with Big Trip - a high-ABV brew full of flavor from the Southeast’s leading craft brand ATLANTA, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “ [...]
Invivyd Announces Partnership with World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention
22/01/2026
The educational campaign will focus on teaching the American public about antibodies and preventing infectious disease The collaboration will advance public understanding of antibodies as a centerpiece of modern [...]
Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile
22/01/2026
Amendment reduces and simplifies royalty structure on Teverelix ® from ~4% to 2% while preserving global rights and IP control The Company is developing Teverelix ® as a first in class market product for Acute Urinary [...]
Plus Therapeutics Provides Business Update on REYOBIQ™ Clinical Program and U.S. CNSide® Commercialization
22/01/2026
Expands CNSide Clinical License in State of Pennsylvania HOUSTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision [...]
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair
22/01/2026
CARMEL, Ind., Jan. 22, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide [...]
CORXEL Announces $287 million Series D1 Financing to Further Advance Its Cardiometabolic Pipeline including Oral Small Molecule GLP-1 Receptor Agonist
22/01/2026
Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital Management (SR One), TCG Crossover (TCGX), RA Capital Management, HBM Healthcare [...]
Protara Therapeutics to Present Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Unresponsive NMIBC Patients at the ASCO Genitourinary Cancers Symposium
22/01/2026
NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that [...]
Catheter Precision Receives First Purchase Order for LockeT in Germany
22/01/2026
FORT MILL, S.C., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac [...]
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention
22/01/2026
Partnership adds a travel-focused consumer telehealth platform to the ARAKODA ® marketing strategy, offering a new convenience to people planning travel to malaria-endemic regions of the world ARAKODA is the only FDA- [...]
NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board
22/01/2026
Dr. Miller’s appointment further enhances NKGen’s scientific and clinical advisory capabilities as the Company advances its research in Alzheimer’s and other related neurodegenerative diseases SANTA ANA, Calif., Jan. 22 [...]
Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
22/01/2026
PARIS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery technology, is [...]
Resalis Therapeutics Appoints Sandor Batkai as Medical Director
22/01/2026
Torino, Italy, January 22 – Resalis Therapeutics , a biotechnology company pioneering microRNA-targeted therapies, today announced the appointment of Sandor Batkai , MD, PhD, as Medical Director. Dr. Batkai is a [...]
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
22/01/2026
ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, [...]
Care@Home for Life Appoints Aurelian Anghelusiu as Chief Relationship Officer to Lead Human-Centered Growth Strategy
22/01/2026
Miami, FL, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Care@Home for Life, a company dedicated to redefining how Americans age at home, today announced the appointment of Aurelian Anghelusiu as Chief Relationship Officer. In this [...]

Pages